ARTICLE | Financial News
Heptares secures $21 million in series B
June 28, 2013 1:17 AM UTC
Heptares Therapeutics Ltd. (Welwyn Garden City, U.K.) secured $21 million in a tranched series B round co-led by new investor Stanley Family Foundation and existing investor Clarus Ventures. Existing ...